The Degarelix market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Degarelix market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Degarelix global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 120 mg per vial segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Degarelix include Ferring, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Degarelix market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
120 mg per vial
80 mg per vial
Market segment by Application, can be divided into
Hospital
Drug store
Market segment by players, this report covers
Ferring
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Degarelix product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Degarelix, with revenue, gross margin and global market share of Degarelix from 2019 to 2022.
Chapter 3, the Degarelix competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Degarelix market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Degarelix research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Degarelix
1.2 Classification of Degarelix by Type
1.2.1 Overview: Global Degarelix Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Degarelix Revenue Market Share by Type in 2021
1.2.3 120 mg per vial
1.2.4 80 mg per vial
1.3 Global Degarelix Market by Application
1.3.1 Overview: Global Degarelix Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Degarelix Market Size & Forecast
1.5 Global Degarelix Market Size and Forecast by Region
1.5.1 Global Degarelix Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Degarelix Market Size by Region, (2017-2022)
1.5.3 North America Degarelix Market Size and Prospect (2017-2028)
1.5.4 Europe Degarelix Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Degarelix Market Size and Prospect (2017-2028)
1.5.6 South America Degarelix Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Degarelix Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Degarelix Market Drivers
1.6.2 Degarelix Market Restraints
1.6.3 Degarelix Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Ferring
2.1.1 Ferring Details
2.1.2 Ferring Major Business
2.1.3 Ferring Degarelix Product and Solutions
2.1.4 Ferring Degarelix Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Ferring Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Degarelix Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Degarelix Players Market Share in 2021
3.2.2 Top 10 Degarelix Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Degarelix Players Head Office, Products and Services Provided
3.4 Degarelix Mergers & Acquisitions
3.5 Degarelix New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Degarelix Revenue and Market Share by Type (2017-2022)
4.2 Global Degarelix Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Degarelix Revenue Market Share by Application (2017-2022)
5.2 Global Degarelix Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Degarelix Revenue by Type (2017-2028)
6.2 North America Degarelix Revenue by Application (2017-2028)
6.3 North America Degarelix Market Size by Country
6.3.1 North America Degarelix Revenue by Country (2017-2028)
6.3.2 United States Degarelix Market Size and Forecast (2017-2028)
6.3.3 Canada Degarelix Market Size and Forecast (2017-2028)
6.3.4 Mexico Degarelix Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Degarelix Revenue by Type (2017-2028)
7.2 Europe Degarelix Revenue by Application (2017-2028)
7.3 Europe Degarelix Market Size by Country
7.3.1 Europe Degarelix Revenue by Country (2017-2028)
7.3.2 Germany Degarelix Market Size and Forecast (2017-2028)
7.3.3 France Degarelix Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Degarelix Market Size and Forecast (2017-2028)
7.3.5 Russia Degarelix Market Size and Forecast (2017-2028)
7.3.6 Italy Degarelix Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Degarelix Revenue by Type (2017-2028)
8.2 Asia-Pacific Degarelix Revenue by Application (2017-2028)
8.3 Asia-Pacific Degarelix Market Size by Region
8.3.1 Asia-Pacific Degarelix Revenue by Region (2017-2028)
8.3.2 China Degarelix Market Size and Forecast (2017-2028)
8.3.3 Japan Degarelix Market Size and Forecast (2017-2028)
8.3.4 South Korea Degarelix Market Size and Forecast (2017-2028)
8.3.5 India Degarelix Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Degarelix Market Size and Forecast (2017-2028)
8.3.7 Australia Degarelix Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Degarelix Revenue by Type (2017-2028)
9.2 South America Degarelix Revenue by Application (2017-2028)
9.3 South America Degarelix Market Size by Country
9.3.1 South America Degarelix Revenue by Country (2017-2028)
9.3.2 Brazil Degarelix Market Size and Forecast (2017-2028)
9.3.3 Argentina Degarelix Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Degarelix Revenue by Type (2017-2028)
10.2 Middle East & Africa Degarelix Revenue by Application (2017-2028)
10.3 Middle East & Africa Degarelix Market Size by Country
10.3.1 Middle East & Africa Degarelix Revenue by Country (2017-2028)
10.3.2 Turkey Degarelix Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Degarelix Market Size and Forecast (2017-2028)
10.3.4 UAE Degarelix Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Degarelix Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Degarelix Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Degarelix Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Degarelix Revenue (USD Million) by Region (2017-2022)
Table 5. Global Degarelix Revenue Market Share by Region (2023-2028)
Table 6. Ferring Corporate Information, Head Office, and Major Competitors
Table 7. Ferring Major Business
Table 8. Ferring Degarelix Product and Solutions
Table 9. Ferring Degarelix Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Global Degarelix Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 11. Global Degarelix Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 12. Breakdown of Degarelix by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Degarelix Players Head Office, Products and Services Provided
Table 14. Degarelix Mergers & Acquisitions in the Past Five Years
Table 15. Degarelix New Entrants and Expansion Plans
Table 16. Global Degarelix Revenue (USD Million) by Type (2017-2022)
Table 17. Global Degarelix Revenue Share by Type (2017-2022)
Table 18. Global Degarelix Revenue Forecast by Type (2023-2028)
Table 19. Global Degarelix Revenue by Application (2017-2022)
Table 20. Global Degarelix Revenue Forecast by Application (2023-2028)
Table 21. North America Degarelix Revenue by Type (2017-2022) & (USD Million)
Table 22. North America Degarelix Revenue by Type (2023-2028) & (USD Million)
Table 23. North America Degarelix Revenue by Application (2017-2022) & (USD Million)
Table 24. North America Degarelix Revenue by Application (2023-2028) & (USD Million)
Table 25. North America Degarelix Revenue by Country (2017-2022) & (USD Million)
Table 26. North America Degarelix Revenue by Country (2023-2028) & (USD Million)
Table 27. Europe Degarelix Revenue by Type (2017-2022) & (USD Million)
Table 28. Europe Degarelix Revenue by Type (2023-2028) & (USD Million)
Table 29. Europe Degarelix Revenue by Application (2017-2022) & (USD Million)
Table 30. Europe Degarelix Revenue by Application (2023-2028) & (USD Million)
Table 31. Europe Degarelix Revenue by Country (2017-2022) & (USD Million)
Table 32. Europe Degarelix Revenue by Country (2023-2028) & (USD Million)
Table 33. Asia-Pacific Degarelix Revenue by Type (2017-2022) & (USD Million)
Table 34. Asia-Pacific Degarelix Revenue by Type (2023-2028) & (USD Million)
Table 35. Asia-Pacific Degarelix Revenue by Application (2017-2022) & (USD Million)
Table 36. Asia-Pacific Degarelix Revenue by Application (2023-2028) & (USD Million)
Table 37. Asia-Pacific Degarelix Revenue by Region (2017-2022) & (USD Million)
Table 38. Asia-Pacific Degarelix Revenue by Region (2023-2028) & (USD Million)
Table 39. South America Degarelix Revenue by Type (2017-2022) & (USD Million)
Table 40. South America Degarelix Revenue by Type (2023-2028) & (USD Million)
Table 41. South America Degarelix Revenue by Application (2017-2022) & (USD Million)
Table 42. South America Degarelix Revenue by Application (2023-2028) & (USD Million)
Table 43. South America Degarelix Revenue by Country (2017-2022) & (USD Million)
Table 44. South America Degarelix Revenue by Country (2023-2028) & (USD Million)
Table 45. Middle East & Africa Degarelix Revenue by Type (2017-2022) & (USD Million)
Table 46. Middle East & Africa Degarelix Revenue by Type (2023-2028) & (USD Million)
Table 47. Middle East & Africa Degarelix Revenue by Application (2017-2022) & (USD Million)
Table 48. Middle East & Africa Degarelix Revenue by Application (2023-2028) & (USD Million)
Table 49. Middle East & Africa Degarelix Revenue by Country (2017-2022) & (USD Million)
Table 50. Middle East & Africa Degarelix Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Degarelix Picture
Figure 2. Global Degarelix Revenue Market Share by Type in 2021
Figure 3. 120 mg per vial
Figure 4. 80 mg per vial
Figure 5. Degarelix Revenue Market Share by Application in 2021
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Degarelix Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Degarelix Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Degarelix Revenue Market Share by Region (2017-2028)
Figure 11. Global Degarelix Revenue Market Share by Region in 2021
Figure 12. North America Degarelix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Degarelix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Degarelix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Degarelix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Degarelix Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Degarelix Market Drivers
Figure 18. Degarelix Market Restraints
Figure 19. Degarelix Market Trends
Figure 20. Ferring Recent Developments and Future Plans
Figure 21. Global Degarelix Revenue Share by Players in 2021
Figure 22. Degarelix Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 23. Global Top 3 Players Degarelix Revenue Market Share in 2021
Figure 24. Global Top 10 Players Degarelix Revenue Market Share in 2021
Figure 25. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 26. Global Degarelix Revenue Share by Type in 2021
Figure 27. Global Degarelix Market Share Forecast by Type (2023-2028)
Figure 28. Global Degarelix Revenue Share by Application in 2021
Figure 29. Global Degarelix Market Share Forecast by Application (2023-2028)
Figure 30. North America Degarelix Sales Market Share by Type (2017-2028)
Figure 31. North America Degarelix Sales Market Share by Application (2017-2028)
Figure 32. North America Degarelix Revenue Market Share by Country (2017-2028)
Figure 33. United States Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 34. Canada Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 35. Mexico Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 36. Europe Degarelix Sales Market Share by Type (2017-2028)
Figure 37. Europe Degarelix Sales Market Share by Application (2017-2028)
Figure 38. Europe Degarelix Revenue Market Share by Country (2017-2028)
Figure 39. Germany Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. France Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. United Kingdom Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Russia Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Italy Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Asia-Pacific Degarelix Sales Market Share by Type (2017-2028)
Figure 45. Asia-Pacific Degarelix Sales Market Share by Application (2017-2028)
Figure 46. Asia-Pacific Degarelix Revenue Market Share by Region (2017-2028)
Figure 47. China Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Japan Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. South Korea Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. India Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Southeast Asia Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Australia Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. South America Degarelix Sales Market Share by Type (2017-2028)
Figure 54. South America Degarelix Sales Market Share by Application (2017-2028)
Figure 55. South America Degarelix Revenue Market Share by Country (2017-2028)
Figure 56. Brazil Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Argentina Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Middle East and Africa Degarelix Sales Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Degarelix Sales Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Degarelix Revenue Market Share by Country (2017-2028)
Figure 61. Turkey Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Saudi Arabia Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. UAE Degarelix Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Methodology
Figure 65. Research Process and Data Source